Feature Articles

US Department of Energy (DOE) Undersecretary for Science Paul Dabbar, leaders from DOE's Brookhaven National Laboratory (Brookhaven Lab) and Thomas Jefferson National Accelerator Facility (Jefferson Lab), and elected officials from New York State and Virginia today commemorated the start of the Electron-Ion Collider project.

Joshua Carter is a co-founder and the CEO of Helix BioStructures, a contract research organization serving the pharmaceutical industry in early-phase drug discovery. Since starting Helix Biostructures in 2017, Carter has leveraged the fast-paced, industrial capabilities of NSLS-II to perform x-ray crystallography experiments for his high volume of clients. Through Carter's work at NSLS-II, in addition to other services his company provides, Helix Biostructures has helped the pharmaceutical industry develop and improve therapies for a variety of diseases.